There is increasing evidence that doxycycline post-exposure prophylaxis (doxy-PEP) is effective for preventing sexually transmitted infections among high-risk patients, particularly in patients using HIV pre-exposure prophylaxis.1–3 However, this benefit must be weighed against potential risks, including selection of antimicrobial resistance. Using whole genome sequencing data of 2375 gonococcal isolates from the 2018 Euro-GASP survey, Vanbaelen and colleagues4 showed that N gonorrhoeae tetracycline resistance-associated mutations and genes are often co-selected with additional antimicrobial resistance markers.
No takes yet. Share an insight, caveat, or question.
Whiley et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: